SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001558370-17-001883
Filing Date
2017-03-16
Accepted
2017-03-16 16:02:33
Documents
7
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A idra_currentfolio10ka.htm 10-K/A 675708
2 EX-10.57 idra_ex1057.htm EX-10.57 89528
3 EX-31.1 idra_ex311.htm EX-31.1 12330
4 EX-31.2 idra_ex312.htm EX-31.2 12339
5 GRAPHIC idraex1057001.jpg GRAPHIC 40735
6 GRAPHIC idraex1057002.jpg GRAPHIC 36101
7 GRAPHIC idraex1057003.jpg GRAPHIC 2523
  Complete submission text file 0001558370-17-001883.txt   900514
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-31918 | Film No.: 17694445
SIC: 2836 Biological Products, (No Diagnostic Substances)